http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102924430-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_078cb8366425c7f7bb46338421d23406
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c031f2e28a040b8bb6280be57b11c7de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4d42aa05f7d30bd16181d358fdd4e77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0ed8688b1febdee564700ded77b48e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab17765e0a67fc1d09bd370779f2055d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e069914601b8151de5f0eb58911f6a7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d63602cf768fc52f3e7b670e835d1a
publicationDate 2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102924430-A
titleOfInvention Desloratadine derivative and its preparation method and use
abstract The invention relates to a class of desloratadine derivatives and a preparation method and use thereof. Specifically, it relates to a class of desloratadine derivatives with the structure of formula I and pharmaceutically acceptable salts thereof and preparation methods thereof, desloratadine derivatives of the structure of formula I and pharmaceutically acceptable salts thereof Pharmaceutical composition as an active ingredient and its role in the prevention or treatment of arginine vasopressin V1a receptor, arginine vasopressin V1b receptor, arginine vasopressin V2 receptor, sympathetic nervous system or kidney Use in diseases related to the hormone-angiotensin-aldosterone system.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103936713-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104292211-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103936713-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103965162-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104418836-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4053116-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098543-A
priorityDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9510514-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414877687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154444700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414863480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416025549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433037836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409442967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465398028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147951221

Total number of triples: 43.